Endobronchial valve therapy for emphysema improves lung function and quality of life, finds research
Written By : Jacinthlyn Sylvia
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-04-17 00:45 GMT | Update On 2024-04-17 06:20 GMT
Advertisement
A new study published in the Annals of the American Thoracic Society revealed the long-term efficacy of the Spiration Valve System (SVS) in treating severe heterogeneous emphysema. The EMPROVE study was conducted over a 24-month period that marks a significant advancement in understanding and managing this debilitating respiratory condition. EMPROVE trial is one of the first rigorous comparison between treatment and control groups over an extended follow-up period.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.